<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04306133</url>
  </required_header>
  <id_info>
    <org_study_id>29/20 PAR ComEt CBM</org_study_id>
    <nct_id>NCT04306133</nct_id>
  </id_info>
  <brief_title>PENG Block Combined to Wound Infiltration for Hip Replacement</brief_title>
  <official_title>Pericapsular Nerve Group (PENG) Block Combined to Wound Infiltration vs. Wound Infiltration Alone for Postoperative Analgesia After Total Hip Replacement: a Prospective Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Campus Bio-Medico University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Campus Bio-Medico University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study analyze the effect of Pericapsular Nerve Group (PENG) Block combined to wound
      infiltration for analgesia after elective hip replacement.

      Half of participants will receive a PENG Block combined with wound infiltration, while the
      other half will receive wound infiltration alone.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 7, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 24, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maximum Pain Score</measure>
    <time_frame>24 hours</time_frame>
    <description>A visual analog pain scale anchored by &quot;no pain&quot; (score of 0) and &quot;pain as bad as it could be&quot; or &quot;worst imaginable pain&quot; (score of 100 [100‐mm scale]) will be used to evaluate pain during 48 h after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total opioids consumption</measure>
    <time_frame>48 hours</time_frame>
    <description>Total of Sublingual Sufentanil tablets released</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to first opioid</measure>
    <time_frame>48 hours</time_frame>
    <description>Time (hours) from the end of surgery to the first opioid administration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of hip motion</measure>
    <time_frame>24 hours</time_frame>
    <description>Degrees of hip flexion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to ambulation</measure>
    <time_frame>48 hours</time_frame>
    <description>Time until the patient is able to stand up and walk with or without assistive devices</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quadriceps weakness</measure>
    <time_frame>48 hours</time_frame>
    <description>Presence of weakness of the quadriceps using a scale where 0= no effect; 1 = knee flexion possible but not hip flexion; 2 = absence of knee and hip flexion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of block complications</measure>
    <time_frame>48 hours</time_frame>
    <description>Any complications or side effects of the blocks, such as local infection, intravascular injection of local anesthetics and immediate systemic toxicity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioids side effects</measure>
    <time_frame>48 hours</time_frame>
    <description>The presence or absence of opioids side effects such as drowsiness, desaturation, nausea and vomiting</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Analgesia</condition>
  <condition>Hip Arthropathy</condition>
  <condition>Acute Pain</condition>
  <condition>Pain</condition>
  <condition>Postoperative Complications</condition>
  <arm_group>
    <arm_group_label>PENG BLOCK AND WOUND INFILTRATION</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receiving PENG block combined to wound infiltration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>WOUND INFILTRATION</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants receiving wound infiltration alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PENG block</intervention_name>
    <description>After performing spinal anesthesia, PENG block with 20 mL of 0.5 % Ropivacaine will be executed as described by Giron-Arongo et al with a low frequency curvilinear probe. A 22G 80 mm needle (Stimuplex Ultra 360, Braun ) will be used.</description>
    <arm_group_label>PENG BLOCK AND WOUND INFILTRATION</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Wound Infiltration</intervention_name>
    <description>At the end of operation, the surgeon will perform wound infiltration with 20 mL of 0.5 % Ropivacaine.</description>
    <arm_group_label>PENG BLOCK AND WOUND INFILTRATION</arm_group_label>
    <arm_group_label>WOUND INFILTRATION</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective hip replacement surgery

          -  ASA physical status score &lt; 4

        Exclusion Criteria:

          -  Contraindications to regional anesthesia

          -  ASA physical status score ≥ 4

          -  Patient's refusal or inability to sing the informed consent

          -  Pre-operatively therapy with opioids

          -  Allergies to any drug provided by the study protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giuseppe Pascarella, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Campus Biomedico of Rome</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Giuseppe Pascarella, MD</last_name>
    <phone>00393204022283</phone>
    <email>g.pascarella@unicampus.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Università Campus Biomedico</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuseppe Pascarella, MD</last_name>
      <phone>00393204022283</phone>
      <email>g.pascarella@unicampus.it</email>
    </contact>
    <contact_backup>
      <last_name>MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Giuseppe Pascarella, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Short AJ, Barnett JJG, Gofeld M, Baig E, Lam K, Agur AMR, Peng PWH. Anatomic Study of Innervation of the Anterior Hip Capsule: Implication for Image-Guided Intervention. Reg Anesth Pain Med. 2018 Feb;43(2):186-192. doi: 10.1097/AAP.0000000000000701.</citation>
    <PMID>29140962</PMID>
  </reference>
  <results_reference>
    <citation>Girón-Arango L, Peng PWH, Chin KJ, Brull R, Perlas A. Pericapsular Nerve Group (PENG) Block for Hip Fracture. Reg Anesth Pain Med. 2018 Nov;43(8):859-863. doi: 10.1097/AAP.0000000000000847.</citation>
    <PMID>30063657</PMID>
  </results_reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 8, 2020</study_first_submitted>
  <study_first_submitted_qc>March 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2020</study_first_posted>
  <last_update_submitted>March 10, 2020</last_update_submitted>
  <last_update_submitted_qc>March 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Campus Bio-Medico University</investigator_affiliation>
    <investigator_full_name>Giuseppe Pascarella</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>regional anesthesia</keyword>
  <keyword>hip surgery</keyword>
  <keyword>PENG</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Acute Pain</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

